Lab21 Extends CPA Accreditation
Lab21 Limited has announced that its Clinical Laboratory Division has extended its Clinical Pathology accreditation (CPA) scope to include Molecular Biology and Virology in addition to Biochemistry.
The accreditation was awarded by Clinical Pathology Accreditation (UK), the quality assurance agency that verifies the quality compliance of the UK’s NHS and private sector laboratories.
Lab21’s Clinical Laboratory, which is based in Cambridge, performs molecular diagnostic testing in Oncology, HIV and Hepatitis with a focus on therapy management enabling health professionals to improve outcomes for their patients. Customers include NHS hospitals, private sector clinics and pharmaceutical companies across the globe.
This latest accreditation builds on Lab21’s existing quality assurance portfolio, including the quality management standards ISO 9001:2008 and ISO 13485 and Good Clinical Laboratory Practice (GCLP).
Graham Mullis, CEO of Lab21, commented: “I am delighted that our laboratories in Cambridge have been awarded the extended CPA accreditation status. This award underlines the commitment that Lab21 and our staff have to the provision of a quality service.”
Mike Annable, Divisional Director of Lab21’s Clinical Laboratory division, added “CPA accreditation endorses the quality of our laboratory operations. Lab21 is committed to the provision of independently validated services that meet the requirements of the increasingly complex regulatory framework covering the use of in vitro diagnostics.”
Other news from the department politics & laws
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
